Understanding the Link Between COVID- and Autoimmune Disorders

The ongoing COVID-19 pandemic has brought to light several long-term health implications, including a potential link between the virus and autoimmune disorders. Emerging evidence suggests that individuals who have recovered from COVID-19 may be at an increased risk of developing autoimmune diseases.

Research indicates that the virus may trigger an aberrant immune response, causing the body’s immune system to attack its own tissues and organs. This dysregulation can lead to the development of various autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis.

One possible explanation for this link is the viral-induced inflammation that persists even after the resolution of COVID-19 symptoms. This chronic inflammation can disrupt normal immune function, making individuals more susceptible to autoimmune diseases.

A study revealed that 83% of patients with Long COVID develop latent autoimmunity and 62% present with polyautoimmunity. More than 85% of patients had anti-SARS-CoV-2 IgG antibodies that positively correlated with autoantibodies, age, and body mass index (BMI) [37].

While further studies are needed to fully understand the connection between COVID-19 and autoimmune disorders, it is crucial to monitor and address any potential long-term health effects in individuals who have recovered from the virus. Early detection and appropriate management of autoimmune conditions can significantly improve outcomes and quality of life for affected individuals.

Learn more about the autoimmune conditions we can help you with